WeedMD To Manufacture Mary's Medicinals Products
Pursuant to the agreement, WeedMD opted to produce a suite of Mary's Medicinals' products, including transdermal gels and patches, as well as topicals.
The Toronto-based company confirmed it would utilize its input biomass and its extraction hub CX Industries.
The execution of the deal is expected later this year, the Wednesday press release said.
WeedMD also agreed to market, sell, and distribute Mary's Medicinals' products within Canada.
The company targets provincial adult-use and direct-to-consumer medical as well as wellness markets.
Mary's CEO Jacques Panis said they are excited to team up with WeedMD and its CX extraction team "that brings unparalleled expertise in cultivation and extraction" aiming to "capture unique next-level distribution channels."
Angelo Tsebelis, WeedMD's CEO, stated they are proud that Mary's selected it as an exclusive Canadian producer and distributor.
Tsebelis added he is satisfied to develop Mary's "renowned products in-house."
Mary's Brands recently partnered with PetSmart stores earlier this year to promote Mary's Tails CBD pet line, increasing its footprint in Colorado, Indiana, Oregon, Tennessee, and Kentucky.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.